NEKTAR THERAPEUTICS Quarterly Entity Common Stock, Shares Outstanding from Q1 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Nektar Therapeutics quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2011 to Q3 2024.
  • Nektar Therapeutics Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 184M shares, a 3.31% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 184M -6.31M -3.31% Nov 1, 2024 10-Q 2024-11-08
Q2 2024 184M -6.04M -3.18% Aug 2, 2024 10-Q 2024-08-09
Q1 2024 184M -5.61M -2.97% May 2, 2024 10-Q 2024-05-10
Q3 2023 191M +2.82M +1.5% Oct 31, 2023 10-Q 2023-11-08
Q2 2023 190M +2.71M +1.45% Aug 1, 2023 10-Q 2023-08-09
Q1 2023 189M +2.96M +1.59% May 2, 2023 10-Q 2023-05-10
Q3 2022 188M +3.4M +1.84% Oct 27, 2022 10-Q 2022-11-04
Q2 2022 187M +3.6M +1.96% Jul 29, 2022 10-Q 2022-08-05
Q1 2022 186M +3.97M +2.18% Apr 29, 2022 10-Q 2022-05-06
Q3 2021 185M +5.16M +2.88% Oct 29, 2021 10-Q 2021-11-05
Q2 2021 184M +4.9M +2.74% Jul 30, 2021 10-Q 2021-08-06
Q1 2021 182M +4.32M +2.43% Apr 30, 2021 10-Q 2021-05-07
Q3 2020 179M +3.48M +1.98% Oct 30, 2020 10-Q 2020-11-06
Q2 2020 179M +3.63M +2.07% Jul 31, 2020 10-Q 2020-08-07
Q1 2020 178M +3.68M +2.11% May 1, 2020 10-Q 2020-05-08
Q3 2019 176M +2.84M +1.64% Nov 1, 2019 10-Q 2019-11-07
Q2 2019 175M +2.81M +1.63% Aug 1, 2019 10-Q 2019-08-09
Q1 2019 174M +2.9M +1.7% May 1, 2019 10-Q 2019-05-09
Q3 2018 173M +15.6M +9.92% Nov 1, 2018 10-Q 2018-11-08
Q2 2018 172M +16.1M +10.3% Aug 3, 2018 10-Q 2018-08-09
Q1 2018 171M +16.3M +10.5% May 3, 2018 10-Q 2018-05-10
Q3 2017 157M +4.63M +3.03% Nov 2, 2017 10-Q 2017-11-08
Q2 2017 156M +19.6M +14.3% Aug 3, 2017 10-Q 2017-08-09
Q1 2017 155M +18.9M +13.9% May 4, 2017 10-Q 2017-05-10
Q3 2016 153M +19.4M +14.5% Oct 27, 2016 10-Q 2016-11-04
Q2 2016 137M +4.36M +3.3% Jul 28, 2016 10-Q 2016-08-04
Q1 2016 136M +4.74M +3.6% Apr 27, 2016 10-Q 2016-05-04
Q3 2015 133M +5.01M +3.9% Oct 29, 2015 10-Q 2015-11-06
Q2 2015 132M +5.07M +3.98% Jul 30, 2015 10-Q 2015-08-06
Q1 2015 132M +4.55M +3.58% Apr 23, 2015 10-Q 2015-05-01
Q3 2014 128M +12.3M +10.6% Oct 30, 2014 10-Q 2014-11-07
Q2 2014 127M +11.5M +9.97% Jul 24, 2014 10-Q 2014-08-01
Q1 2014 127M +11.5M +9.92% Apr 30, 2014 10-Q 2014-05-08
Q3 2013 116M +947K +0.82% Oct 31, 2013 10-Q 2013-11-07
Q2 2013 116M +848K +0.74% Aug 1, 2013 10-Q 2013-08-09
Q1 2013 116M +912K +0.8% Apr 30, 2013 10-Q 2013-05-09
Q3 2012 115M +742K +0.65% Nov 5, 2012 10-Q 2012-11-09
Q2 2012 115M +491K +0.43% Aug 6, 2012 10-Q 2012-08-09
Q1 2012 115M +538K +0.47% Apr 27, 2012 10-Q 2012-05-04
Q3 2011 114M Oct 31, 2011 10-Q 2011-11-04
Q2 2011 114M Aug 1, 2011 10-Q 2011-08-05
Q1 2011 114M Apr 25, 2011 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.